CN Patent

CN104395332A — 甲基巴多索隆的2,2-二氟丙酰胺衍生物、其多晶型物及使用方法

Assigned to Riata Pharmaceutical Holding Co ltd · Expires 2015-03-04 · 11y expired

What this patent protects

本发明大体上涉及以下化合物：N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-氰基-2，2,6a,6b,9,9,12a-七甲基-10,14-二氧代-1，2,3，4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-十八氢苉-4a-基)-2,2-二氟丙酰胺、其多晶型物、其制备和使用方法、其药物组合物以及其试剂盒和制品。

USPTO Abstract

本发明大体上涉及以下化合物：N-((4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-氰基-2，2,6a,6b,9,9,12a-七甲基-10,14-二氧代-1，2,3，4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-十八氢苉-4a-基)-2,2-二氟丙酰胺、其多晶型物、其制备和使用方法、其药物组合物以及其试剂盒和制品。

Drugs covered by this patent

Patent Metadata

Patent number
CN104395332A
Jurisdiction
CN
Classification
—
Expires
2015-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Riata Pharmaceutical Holding Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.